Jenette Creaney

17PUBLICATIONS
46CO-AUTHORS
Molecular targetsPredictive and prognostic markersImmunogenetics (incl. genetic immunology)Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jan 28, 2026
Hidden Targets in Cancer Immunotherapy: The Potential of "Dark Matter" Neoantigens.

Francois Xavier Rwandamuriye, Alec J Redwood, Jenette Creaney

|Nov 28, 2023
Genomic Landscape of Pleural Mesothelioma and Therapeutic Aftermaths.

Alistair Nash, Jenette Creaney

|Nov 01, 2023
Computational immunogenomic approaches to predict response to cancer immunotherapies.

Venkateswar Addala, Felicity Newell, John V Pearson

|Feb 21, 2022
What's next in cancer immunotherapy? - The promise and challenges of neoantigen vaccination.

Alec J Redwood, Ian M Dick, Jenette Creaney

|Jul 21, 2021
Characterization of neoantigen-specific T cells in cancer resistant to immune checkpoint therapies.

Shamin Li, Yannick Simoni, Summer Zhuang

Pageof 3